Stockreport

Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE-IgAN Study [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF from the Phase III APPLAUSE-IgAN study of Fabhalta® in IgA nephropathy (IgAN). The company reported that Fabhalta exhibited a statistically significant, clinically meani [Read more]